A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.
MIA’s Justin Karter interviews psychiatrist Awais Aftab about how “conceptual competence” uses philosophy to transform psychiatry.
School Psychologist Scott Greenspan discusses how to promote exercise and mental wellbeing for adolescents stuck indoors during the pandemic.
MIA's Ana Florence interviews United Nations Special Rapporteur Dainius Pūras about his own journey as a psychiatrist and the future of rights-based approaches to mental health.
MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.
A network analysis of participants’ social media use and well-being reveals complex links with social capital but a minimal association with attentional control.
People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.
Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.
Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.
MIA's Micah Ingle interviews the anthropologist Ian Puppe on how the imposition of psychiatric treatments can lead to harmful iatrogenic effects with Indigenous peoples.
A study, recently published in Psychological Medicine, examined the cognitive functioning of individuals with schizophrenia who discontinued antipsychotics, and those who maintained their antipsychotic...
Peer-Support Groups Were Right, Guidelines Were Wrong: Dr. Mark Horowitz on Tapering Off Antidepressants
In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.
MIA's Zenobia Morrill interviews Lucy Johnstone about the reaction to the Power Threat Meaning Framework, her life influences, and her hopes for the future.
Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.
Well known Stanford University researcher John Ioannidis published a new paper this week criticizing the use and production of systematic reviews and meta-analyses, often...
A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...
Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.
A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.
A new study has found that children and adolescents taking a high dose of antipsychotics are almost twice as likely to die of any cause than children on other types of medications.
A new study suggests that taking antidepressants impairs empathy, while the experience of depression itself does not.
Researchers at Johns Hopkins test paroxetine on developing brain cells and discover numerous neurotoxic effects.
Prominent researchers in psychiatry urge the field to move away from a rigid biological focus toward social and psychological perspectives to meet the needs of today’s world.
A new review of antipsychotic trials conducted over the last 24 years finds that the placebo response rate is steadily increasing, and drug response is decreasing.
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
Researchers find that nearly half of cognitive behavioral therapy (CBT) patients experience treatment side effects.